Evropska unija - slovenščina - EMA (European Medicines Agency)

aop orphan pharmaceuticals gmbh - ropeginterferon alfa-2b - polycythemia vera - immunostimulants, - besremi je označen kot monotherapy pri odraslih za zdravljenje polycythaemia vera brez simptomatsko splenomegaly.

Evropska unija - slovenščina - EMA (European Medicines Agency)

eli lilly nederland b.v. - baricitinib - artritis, revmatoidni - imunosupresivi - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). zdravilo olumiant se lahko uporablja kot monoterapija ali v kombinaciji z metotreksatom. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.

Evropska unija - slovenščina - EMA (European Medicines Agency)

eli lilly nederland b.v. - insulin lispro - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - zdravljenje diabetesa mellitusa pri odraslih, mladostnikih in otrocih, starih 1 leto in več. zdravljenje diabetesa mellitusa pri odraslih.

Evropska unija - slovenščina - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - leukemija, myeloid, akutna - antineoplastična sredstva - vyxeos liposomal je indiciran za zdravljenje odraslih z novo diagnozo, terapijo, povezanih z akutno mieloično levkemijo (t-aml) ali aml z myelodysplasia povezane spremembe (aml-mrc).

Evropska unija - slovenščina - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - cannabidiol - lennox gastaut syndrome; epilepsies, myoclonic - antiepileptics, - epidyolex je primerna za uporabo kot adjunctive zdravljenje epileptičnih, povezanih z lennox gastaut sindrom (lgs) ali dravet sindrom (ds), v povezavi z papir, za bolnike 2 let in starejši.

Evropska unija - slovenščina - EMA (European Medicines Agency)

mylan pharmaceuticals limited - acetylsalicylic acid, clopidogrel hydrogen sulfate - acute coronary syndrome; myocardial infarction - antitrombotična sredstva - clopidogrel/acetilsalicilne kisline mylan je primerna za sekundarno preprečevanje atherothrombotic dogodkov pri odraslih bolnikih, ki že ob tako clopidogrel in acetilsalicilne kisline (asa). clopidogrel/acetilsalicilne kisline mylan je določen odmerek kombinacije zdravila za nadaljevanje terapije v:non-st segmentu višinskih akutni koronarni sindrom (nestabilna angina pektoris ali ne-q-val, miokardni infarkt), vključno z bolniki, ki opravljajo stent umestitev po perkutani koronarni interventionst segmentu višinskih akutni miokardni infarkt v medicinsko zdravljenih bolnikih, ki izpolnjujejo pogoje za thrombolytic terapija.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

alfasan nederland -

Evropska unija - slovenščina - EMA (European Medicines Agency)

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinalni stromalni tumorji - antineoplastična sredstva - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

Evropska unija - slovenščina - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedem, dedno - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.

Evropska unija - slovenščina - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - imunosupresivi - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).